Premium
Cisplatin‐based Chemotherapy does not Eliminate the Risk of a Second Testicular Cancer
Author(s) -
FOSSÅ SOPHIE D.,
AASS NINA
Publication year - 1989
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1989.tb05951.x
Subject(s) - cisplatin , testicular cancer , medicine , chemotherapy , incidence (geometry) , oncology , germ cell , germ cell tumors , testicular germ cell tumor , cancer , cancer chemotherapy , gynecology , biology , biochemistry , physics , optics , gene
Summary— Of 781 patients with germ cell cancer, 14 developed a second (subsequent) testicular cancer during follow‐up. The incidence was not related to the treatment of the first germ cell cancer. In particular, adequate cisplatin‐based chemotherapy did not reduce the risk of developing a second tumour. Screening programmes in patients with previous germ cell tumours should include all patients, irrespective of prior treatment.